Rupam Tripura
Overview
Explore the profile of Rupam Tripura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
3684
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lek D, Shrestha M, Lhazeen K, Tobgyel T, Kandel S, Dahal G, et al.
Malar J
. 2024 Dec;
23(1):401.
PMID: 39722002
Background: The national malaria control programmes in Cambodia, Nepal, and Bhutan aim to achieve malaria elimination by 2025-2030. While the vivax malaria burden remains challenging, the consistent decline in falciparum...
2.
Betrian M, Umans D, Vanna M, Ol S, Adhikari B, Davoeung C, et al.
PLoS One
. 2024 Dec;
19(12):e0315636.
PMID: 39652531
[This corrects the article DOI: 10.1371/journal.pone.0283405.].
3.
Nayak S, Peto T, Kucharski M, Tripura R, Callery J, Quang Huy D, et al.
Nat Commun
. 2024 Dec;
15(1):10625.
PMID: 39639029
The emergence of Plasmodium falciparum parasites resistant to artemisinins compromises the efficacy of Artemisinin Combination Therapies (ACTs), the global first-line malaria treatment. Artemisinin resistance is a complex genetic trait in...
4.
Chew R, Wynberg E, Liverani M, Rekol H, Nguon C, Dysoley L, et al.
BMJ Open
. 2024 Oct;
14(10):e089616.
PMID: 39424394
Introduction: Acute febrile illness (AFI), traditionally attributed to malaria, is a common reason for seeking primary healthcare in rural South and Southeast Asia. However, malaria transmission has declined while health...
5.
Cassidy-Seyoum S, Chheng K, Chanpheakdey P, Meershoek A, Hsiang M, von Seidlein L, et al.
PLOS Glob Public Health
. 2024 Jul;
4(7):e0003476.
PMID: 39028699
Plasmodium vivax remains a challenge for malaria elimination since it forms dormant liver stages (hypnozoites) that can reactivate after initial infection. 8-aminoquinolone drugs kill hypnozoites but can cause severe hemolysis...
6.
Dhorda M, Kaneko A, Komatsu R, Kc A, Mshamu S, Gesase S, et al.
Science
. 2024 Jul;
385(6706):252-254.
PMID: 39024426
Investment in community health workers is essential.
7.
Kane J, Li X, Kumar S, Button-Simons K, Vendrely Brenneman K, Dahlhoff H, et al.
mBio
. 2024 Jun;
15(7):e0080524.
PMID: 38912775
Piperaquine (PPQ) is widely used in combination with dihydroartemisinin as a first-line treatment against malaria. Multiple genetic drivers of PPQ resistance have been reported, including mutations in the () and...
8.
Ean M, Tripura R, Sothea P, Savoeun U, Peto T, Bunthynn S, et al.
Glob Bioeth
. 2024 Jun;
35(1):2361968.
PMID: 38859929
Engaging young people in health research has been promoted globally. We explored the outcomes of youth advisory group on health and research engagement (YAGHRE) in rural Cambodia. In May 2021,...
9.
Zhang M, Htun N, Islam S, Sen A, Islam A, Neogi A, et al.
BMJ Open
. 2024 Mar;
14(3):e081079.
PMID: 38521526
Introduction: In low-income and middle-income countries in Southeast Asia, the burden of diseases among rural population remains poorly understood, posing a challenge for effective healthcare prioritisation and resource allocation. Addressing...
10.
Dysoley L, Callery J, Bunreth V, Vanna M, Davoeung C, Sovann Y, et al.
Malar J
. 2024 Jan;
23(1):2.
PMID: 38166839
In Southeast Asia malaria elimination is targeted by 2030. Cambodia aims to achieve this by 2025, driven in large part by the urgent need to control the spread of artemisinin-resistant...